Detailed information for compound 1601575

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 354.55 | Formula: C19H34N2O2S
  • H donors: 0 H acceptors: 2 LogP: 5.05 Rotable bonds: 15
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCCCCCC(=O)c1ncc(o1)CCCSCCCN(C)C
  • InChi: 1S/C19H34N2O2S/c1-4-5-6-7-8-12-18(22)19-20-16-17(23-19)11-9-14-24-15-10-13-21(2)3/h16H,4-15H2,1-3H3
  • InChiKey: HUNIZLTVGZYJBW-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Onchocerca volvulus 0.4268 0.2979 0.2079
Trypanosoma cruzi carbonic anhydrase-like protein, putative 0.1323 0.0509 0.5
Loa Loa (eye worm) hypothetical protein 0.3886 0.2659 0.3944
Loa Loa (eye worm) hypothetical protein 0.3191 0.2075 0.3079
Loa Loa (eye worm) hypothetical protein 0.3191 0.2075 0.3079
Leishmania major carbonic anhydrase-like protein 0.1323 0.0509 0.5
Plasmodium falciparum carbonic anhydrase 0.0716 0 0.5
Onchocerca volvulus Matrix metalloproteinase homolog 0.7077 0.5335 0.7501
Echinococcus multilocularis matrix metallopeptidase 7 (M10 family) 1.2639 1 1
Schistosoma mansoni carbonic anhydrase II (carbonate dehydratase II) 0.1323 0.0509 0.1609
Brugia malayi Putative carbonic anhydrase 5 precursor 0.1323 0.0509 0.0755
Schistosoma mansoni matrix metallopeptidase-7 (M10 family) 0.4485 0.3161 1
Loa Loa (eye worm) eukaryotic-type carbonic anhydrase 0.1323 0.0509 0.0755
Trypanosoma brucei carbonic anhydrase-like protein 0.1323 0.0509 0.5
Mycobacterium ulcerans hydrolase 0.3886 0.2659 0.5
Schistosoma mansoni carbonic anhydrase II (carbonate dehydratase II) 0.1323 0.0509 0.1609
Brugia malayi Hemopexin family protein 0.4268 0.2979 0.4419
Mycobacterium leprae PROBABLE HYDROLASE 0.3886 0.2659 0.5
Trypanosoma cruzi carbonic anhydrase-like protein, putative 0.1323 0.0509 0.5
Loa Loa (eye worm) matrixin family protein 0.7077 0.5335 0.7914
Brugia malayi Matrixin family protein 0.3191 0.2075 0.3079
Schistosoma mansoni hypothetical protein 0.4268 0.2979 0.9423
Loa Loa (eye worm) matrixin family protein 0.8753 0.6741 1
Brugia malayi Matrix metalloprotease, N-terminal domain containing protein 0.3886 0.2659 0.3944
Brugia malayi Matrixin family protein 0.8753 0.6741 1
Brugia malayi Matrixin family protein 0.3191 0.2075 0.3079
Echinococcus granulosus carbonic anhydrase II 0.1323 0.0509 0.0509
Loa Loa (eye worm) carbonic anhydrase 3 0.1323 0.0509 0.0755
Mycobacterium tuberculosis Probable peptidoglycan hydrolase 0.3886 0.2659 0.5
Toxoplasma gondii hypothetical protein 0.0716 0 0.5
Onchocerca volvulus Matrilysin homolog 0.8371 0.642 1
Loa Loa (eye worm) hypothetical protein 0.4485 0.3161 0.469
Echinococcus multilocularis carbonic anhydrase II 0.1323 0.0509 0.0509
Brugia malayi Eukaryotic-type carbonic anhydrase family protein 0.1323 0.0509 0.0755
Brugia malayi Matrixin family protein 0.3191 0.2075 0.3079
Brugia malayi Matrixin family protein 0.3191 0.2075 0.3079
Schistosoma mansoni matrix metallopeptidase-9 (M10 family) 0.1489 0.0648 0.2049
Loa Loa (eye worm) matrix metalloproteinase 0.3191 0.2075 0.3079

Activities

Activity type Activity value Assay description Source Reference
Activity (binding) = 64 % Inhibition of Sprague-Dawley rat brain FAAH assessed as residual activity at 10 uM after 60 mins by reverse phase HPLC-based fluorescence method ChEMBL. 22196515

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.